calc hfa icos her2 derived

api.magentlab.comInference derived

POST https://api.magentlab.com/api/calc/hfa_icos_her2

passlisted in Coinbase#754 by calls of 844 on this host

0.005 USDC

per call, as the listing declares it on eip155:8453

Compare with another Every figure as JSON Cite this page

the price, as of 2026-10-12 05:54 UTC · method · pinnable

Validation state: pass; as of 2026-10-12 06:23 UTC · method · pinnable · sweep daily-2026-10-12
Uptime, 7 / 30 / 90 days: 100% / 100% / 100%; as of 2026-10-12 06:23 UTC · method · pinnable · 7 of 7 in 7d, 16 of 16 in 30d, 16 of 16 in 90d
Calls, trailing 30 days: 2; as of 2026-10-12 05:54 UTC · method · pinnable
Unique payers, trailing 30 days: 1; as of 2026-10-12 05:54 UTC · method · pinnable
Last called: 2026-10-05 13:45 UTC; as of 2026-10-12 05:54 UTC · method · pinnable
First observed by TOLLderived: 2026-09-28; as of 2026-09-28 13:51 UTC · method · pinnable · observation began 10 September 2026; listings that predate it show that date
Pricederived: 0.005 USDC; as of 2026-10-12 05:54 UTC · method · pinnable · on eip155:8453
Networks: 1; as of 2026-10-12 05:54 UTC · method · pinnable

Counters

39 observations, 3 of them a change

How has the volume on this endpoint moved?

Calls counted in the trailing 30 days on this endpoint, at every snapshot since 2026-09-28. Each point is a trailing-30-day sum as the registry published it, not a daily rate. The axis is truncated to the range of the data with a break at its foot.

In words

calc hfa icos her2 shares api.magentlab.com with 843 other listed endpoints and is tied 754th by calls with 90 others.

Callers of calc hfa icos her2 supply a JSON body with the field items.

The output example is a json object with path, count and items.

calc hfa icos her2 drew 2 calls from one payer in the trailing 30 days.

The last call to calc hfa icos her2 came 7 days before the snapshot, 2026-10-05.

calc hfa icos her2 is priced at 0.005 USDC on Base.

At api.magentlab.com, calc hfa icos her2 takes POST requests, is listed in the Coinbase registry, and falls under inference by TOLL's rules.

calc hfa icos her2 answered the sweep of 2026-10-12 with a valid 402, as at every sweep since 2026-09-28.

Closest in price to calc hfa icos her2 within inference: marine depth at api.geoprimitives.dev and google ai mode ai mode at x402.openwebninja.com.

calc hfa icos her2 is among the cheapest in inference; 9% of comparable listings ask less.

The wallet paid by calc hfa icos her2 is the payee of 844 endpoints on one host.

The seller's own tags are hfa-icos, her2, cardio-oncology and trastuzumab.

calc hfa icos her2 dropped out of the registry at the pull of 2026-09-30 and was listed again on 2026-09-30.

The price of calc hfa icos her2 is declared by 322 other listings in inference too.

Payment options as declared

the payment options, as of 2026-10-12 05:54 UTC · method · pinnable

Every payment option declared on this listing
registry	network	asset	amount	scheme	pay to
Coinbase	eip155:8453	USDC	0.005 USDC	exact	0x836Be2…c19Ee2

Preflight checks at the last sweep

the checks, as of 2026-10-12 06:23 UTC · method · pinnableendpoint answered HTTP 402

No named check failed.

Validation history, 90 days

Every sweep that observed this endpoint, newest first.

Validation observations over the last 90 days
observed, UTC	state	sweep
2026-10-12 06:23 UTC	pass	daily-2026-10-12
2026-10-11 04:45 UTC	pass	daily-2026-10-11
2026-10-10 12:55 UTC	pass	daily-2026-10-10
2026-10-09 04:49 UTC	pass	daily-2026-10-09
2026-10-08 06:27 UTC	pass	daily-2026-10-08
2026-10-07 05:36 UTC	pass	daily-2026-10-07
2026-10-06 06:33 UTC	pass	daily-2026-10-06
2026-10-05 06:14 UTC	pass	daily-2026-10-05
2026-10-04 09:03 UTC	pass	daily-2026-10-04
2026-10-03 04:19 UTC	pass	daily-2026-10-03
2026-10-02 13:29 UTC	pass	daily-2026-10-02
2026-10-01 06:42 UTC	pass	daily-2026-10-01
2026-09-30 05:59 UTC	pass	daily-2026-09-30
2026-09-29 18:20 UTC	pass	daily-2026-09-29
2026-09-28 16:53 UTC	pass	daily-2026-09-28
2026-09-28 16:02 UTC	pass	new-after-daily-2026-09-28

Registry presence

Presence in a registry, not liveness of the service (method). Newest first.

2026-09-30 22:14 UTCback in Coinbase
2026-09-30 12:32 UTCabsent from Coinbase at this pull
2026-09-28 13:51 UTClisted in Coinbase

Declared input and output, as listed

From the registry record, not validated by TOLL.the declared schema, as of 2026-10-05 13:45 UTC · method · live

The input and output block

{
  "input": {
    "body": {
      "items": [
        {
          "ckd": false,
          "obesity": false,
          "diabetes": false,
          "age_years": 50,
          "arrhythmia": false,
          "mi_or_cabg": false,
          "elevated_bnp": false,
          "hypertension": false,
          "lvef_percent": 60,
          "stable_angina": false,
          "elevated_troponin": false,
          "anthracycline_before_her2": false,
          "prior_remote_anthracycline": false,
          "current_or_significant_smoker": false,
          "severe_valvular_heart_disease": false,
          "heart_failure_or_cardiomyopathy": false,
          "prior_trastuzumab_cardiotoxicity": false,
          "concurrent_anthracycline_and_her2": false,
          "prior_left_chest_or_mediastinal_rt": false
        },
        {
          "ckd": false,
          "obesity": false,
          "diabetes": false,
          "age_years": 50,
          "arrhythmia": false,
          "mi_or_cabg": false,
          "elevated_bnp": false,
          "hypertension": false,
          "lvef_percent": 60,
          "stable_angina": false,
          "elevated_troponin": false,
          "anthracycline_before_her2": false,
          "prior_remote_anthracycline": false,
          "current_or_significant_smoker": false,
          "severe_valvular_heart_disease": false,
          "heart_failure_or_cardiomyopathy": false,
          "prior_trastuzumab_cardiotoxicity": false,
          "concurrent_anthracycline_and_her2": false,
          "prior_left_chest_or_mediastinal_rt": false
        }
      ]
    },
    "type": "http",
    "method": "POST"
  },
  "output": {
    "type": "json",
    "example": {
      "path": "/api/calc/hfa_icos_her2",
      "count": 2,
      "items": [
        {
          "score": 0,
          "formula": "hfa_icos_her2",
          "citation": {
            "id": "lyon-2020",
            "doi": "10.1002/ejhf.1920",
            "pmid": "32458582",
            "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society",
            "source": "Eur J Heart Fail. 2020;22(11):1945-1960",
            "authors": "Lyon AR, Dent S, Stanway S, et al."
          },
          "age_years": 50,
          "max_score": 20,
          "components": [
            {
              "factor": "heart_failure_or_cardiomyopathy",
              "points": 0,
              "present": false
            },
            {
              "factor": "prior_trastuzumab_cardiotoxicity",
              "points": 0,
              "present": false
            },
            {
              "factor": "mi_or_cabg",
              "points": 0,
              "present": false
            },
            {
              "factor": "stable_angina",
              "points": 0,
              "present": false
            },
            {
              "factor": "severe_valvular_heart_disease",
              "points": 0,
              "present": false
            },
            {
              "value": 60,
              "factor": "lvef_lt_50",
              "points": 0,
              "present": false
            },
            {
              "value": 50,
              "factor": "age_ge_80",
              "points": 0,
              "present": false
            },
            {
              "factor": "concurrent_anthracycline_and_her2",
              "points": 0,
              "present": false
            },
            {
              "value": 60,
              "factor": "lvef_50_54",
              "points": 0,
              "present": false
            },
            {
              "factor": "arrhythmia",
              "points": 0,
              "present": false
            },
            {
              "factor": "elevated_troponin",
              "points": 0,
              "present": false
            },
            {
              "factor": "elevated_bnp",
              "points": 0,
              "present": false
            },
            {
              "value": 50,
              "factor": "age_65_79",
              "points": 0,
              "present": false
            },
            {
              "factor": "prior_remote_anthracycline",
              "points": 0,
              "present": false
            },
            {
              "factor": "prior_left_chest_or_mediastinal_rt",
              "points": 0,
              "present": false
            },
            {
              "factor": "hypertension",
              "points": 0,
              "present": false
            },
            {
              "factor": "diabetes",
              "points": 0,
              "present": false
            },
            {
              "factor": "ckd",
              "points": 0,
              "present": false
            },
            {
              "factor": "anthracycline_before_her2",
              "points": 0,
              "present": false
            },
            {
              "factor": "current_or_significant_smoker",
              "points": 0,
              "present": false
            },
            {
              "factor": "obesity",
              "points": 0,
              "present": false
            }
          ],
          "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
          "risk_level": "low",
          "high_present": false,
          "lvef_percent": 60,
          "medium_points": 0,
          "very_high_present": false,
          "formula_expression": "HFA-ICOS HER2 (Lyon 2020): very_high if heart_failure_or_cardiomyopathy or prior_trastuzumab_cardiotoxicity; else high if mi_or_cabg or stable_angina or severe_valvular_heart_disease or lvef_percent<50 or age_years>=80 or concurrent_anthracycline_and_her2 or medium_points>=5; else medium if medium_points 2-4; else low; medium_points = Medium 2 (2) + Medium 1 (1); Medium 2 = lvef 50-54, arrhythmia, elevated_troponin, elevated_bnp, age 65-79, prior_remote_anthracycline, prior_left_chest_or_mediastinal_rt; Medium 1 = hypertension, diabetes, ckd, anthracycline_before_her2 (if not concurrent), current_or_significant_smoker, obesity; cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%",
          "cardiotoxicity_guide": "<2%",
          "anthracycline_before_her2": false,
          "concurrent_anthracycline_and_her2": false
        },
        {
          "score": 0,
          "formula": "hfa_icos_her2",
          "citation": {
            "id": "lyon-2020",
            "doi": "10.1002/ejhf.1920",
            "pmid": "32458582",
            "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society",
            "source": "Eur J Heart Fail. 2020;22(11):1945-1960",
            "authors": "Lyon AR, Dent S, Stanway S, et al."
          },
          "age_years": 50,
          "max_score": 20,
          "components": [
            {
              "factor": "heart_failure_or_cardiomyopathy",
              "points": 0,
              "present": false
            },
            {
              "factor": "prior_trastuzumab_cardiotoxicity",
              "points": 0,
              "present": false
            },
            {
              "factor": "mi_or_cabg",
              "points": 0,
              "present": false
            },
            {
              "factor": "stable_angina",
              "points": 0,
              "present": false
            },
            {
              "factor": "severe_valvular_heart_disease",
              "points": 0,
              "present": false
            },
            {
              "value": 60,
              "factor": "lvef_lt_50",
              "points": 0,
              "present": false
            },
            {
              "value": 50,
              "factor": "age_ge_80",
              "points": 0,
              "present": false
            },
            {
              "factor": "concurrent_anthracycline_and_her2",
              "points": 0,
              "present": false
            },
            {
              "value": 60,
              "factor": "lvef_50_54",
              "points": 0,
              "present": false
            },
            {
              "factor": "arrhythmia",
              "points": 0,
              "present": false
            },
            {
              "factor": "elevated_troponin",
              "points": 0,
              "present": false
            },
            {
              "factor": "elevated_bnp",
              "points": 0,
              "present": false
            },
            {
              "value": 50,
              "factor": "age_65_79",
              "points": 0,
              "present": false
            },
            {
              "factor": "prior_remote_anthracycline",
              "points": 0,
              "present": false
            },
            {
              "factor": "prior_left_chest_or_mediastinal_rt",
              "points": 0,
              "present": false
            },
            {
              "factor": "hypertension",
              "points": 0,
              "present": false
            },
            {
              "factor": "diabetes",
              "points": 0,
              "present": false
            },
            {
              "factor": "ckd",
              "points": 0,
              "present": false
            },
            {
              "factor": "anthracycline_before_her2",
              "points": 0,
              "present": false
            },
            {
              "factor": "current_or_significant_smoker",
              "points": 0,
              "present": false
            },
            {
              "factor": "obesity",
              "points": 0,
              "present": false
            }
          ],
          "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
          "risk_level": "low",
          "high_present": false,
          "lvef_percent": 60,
          "medium_points": 0,
          "very_high_present": false,
          "formula_expression": "HFA-ICOS HER2 (Lyon 2020): very_high if heart_failure_or_cardiomyopathy or prior_trastuzumab_cardiotoxicity; else high if mi_or_cabg or stable_angina or severe_valvular_heart_disease or lvef_percent<50 or age_years>=80 or concurrent_anthracycline_and_her2 or medium_points>=5; else medium if medium_points 2-4; else low; medium_points = Medium 2 (2) + Medium 1 (1); Medium 2 = lvef 50-54, arrhythmia, elevated_troponin, elevated_bnp, age 65-79, prior_remote_anthracycline, prior_left_chest_or_mediastinal_rt; Medium 1 = hypertension, diabetes, ckd, anthracycline_before_her2 (if not concurrent), current_or_significant_smoker, obesity; cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%",
          "cardiotoxicity_guide": "<2%",
          "anthracycline_before_her2": false,
          "concurrent_anthracycline_and_her2": false
        }
      ]
    }
  }
}

What the listing says

Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents). Very high, high, medium, or low from published factors plus Medium 1/2 points; expert-opinion cardiotoxicity guide <2% / 2-9% / 10-19% / >=20%. Concurrent anthracycline is High; sequential anthracycline before HER2 is Medium 1. Deterministic published classification with citation; not a treatment order. magent does not measure LVEF or biomarkers.

the record, 2026-10-05 13:45 UTC · method · pinnable

As declared

POST
eip155:8453
USDC
exact

Every tag is a field on the listing, not a keyword TOLL assigned.

Who is paid

0x836Be2…c19Ee2

Takes payment for 844 endpoints on 1 host.

Among Inference

counted above57%

of 9,557 that carry counters

cheaper than9%

of 9,579 with a comparable price

10,036 endpoints are in this category. 322 declare exactly this price.

the comparison, 2026-10-12 05:54 UTC · method · live

Nearest on price

prompt injection detectagent.pocket.network0.005 USDCpass
marine depthapi.geoprimitives.dev0.005 USDCpass
google ai mode ai modex402.openwebninja.com0.005 USDCpass
llmapi.losbeto.xyz0.005 USDCpass
agent record rubric assertrubric-protocol.com0.005 USDCpass

Same category, nearest declared price, one per payee wallet (method). the list, 2026-10-12 05:54 UTC · method · live

Elsewhere in the record

Cite this page

The pinned URL below renders this page from the snapshot of 2026-10-12 05:54 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).

Plain text

TOLL, "calc hfa icos her2 on api.magentlab.com", snapshot of 2026-10-12 05:54 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-hfa-icos-her2-1d8d29/at/2026-10-12T05-54Z. Accessed [access date].

BibTeX

@misc{toll-e-api-magentlab-com-api-calc-hfa-icos-her2-1d8d29-2026-10-12T05-54Z,
  author = {TOLL},
  title = {calc hfa icos her2 on api.magentlab.com},
  howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-hfa-icos-her2-1d8d29/at/2026-10-12T05-54Z}},
  year = {2026},
  month = {10},
  note = {Pinned view of the snapshot of 2026-10-12 05:54 UTC. Accessed [access date].}
}

Reports and replies about this endpoint

None yet. Anything submitted through the form below is published here with its outcome.

Report an error about calc hfa icos her2, or reply as the named seller